These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8821606)

  • 1. Sequential mutations of gyrA in Escherichia coli associated with quinolone therapy.
    Truong QC; Ouabdesselam S; Hooper DC; Moreau NJ; Soussy CJ
    J Antimicrob Chemother; 1995 Dec; 36(6):1055-9. PubMed ID: 8821606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
    Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
    J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.
    Bachoual R; Tankovic J; Soussy CJ
    Microb Drug Resist; 1998; 4(4):271-6. PubMed ID: 9988045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of single-point gyrA mutations among ciprofloxacin-susceptible Escherichia coli isolates causing urinary tract infections in Latin America.
    Gales AC; Gordon KA; Wilke WW; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 Jan; 36(1):61-4. PubMed ID: 10744370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of plasmid complementation test for determination of quinolone resistance due to changes in the gyrase A protein and identification of conditional quinolone resistance locus.
    Soussy CJ; Wolfson JS; Ng EY; Hooper DC
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2588-92. PubMed ID: 8109921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals.
    Sáenz Y; Zarazaga M; Briñas L; Ruiz-Larrea F; Torres C
    J Antimicrob Chemother; 2003 Apr; 51(4):1001-5. PubMed ID: 12654733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
    Herrera G; Aleixandra V; Urios A; Blanco M
    FEMS Microbiol Lett; 1993 Jan; 106(2):187-91. PubMed ID: 8384139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
    Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
    J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
    Heisig P; Schedletzky H; Falkenstein-Paul H
    Antimicrob Agents Chemother; 1993 Apr; 37(4):696-701. PubMed ID: 8388197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-year survey of quinolone resistance in Escherichia coli causing urinary tract infections.
    Pérez-Trallero E; Urbieta M; Jimenez D; García-Arenzana JM; Cilla G
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):349-51. PubMed ID: 8354301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mutations of gyrA in ciprofloxacin resistant Escherichia coli strains].
    Eraç B; Gill A; Amyes SG; Gülay Z
    Mikrobiyol Bul; 2003; 37(2-3):125-30. PubMed ID: 14593893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology and mutations at gyrA and parC genes of ciprofloxacin-resistant Escherichia coli isolates from a Taiwan medical center.
    Chen JY; Siu LK; Chen YH; Lu PL; Ho M; Peng CF
    Microb Drug Resist; 2001; 7(1):47-53. PubMed ID: 11310803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of mutations at codon 83 of the gyrA gene of quinolone-resistant clinical isolates of Escherichia coli.
    Ruiz J; Marco F; Goñi P; Gallardo F; Mensa J; Trilla A; Jimenez de Anta T; Vila J
    J Antimicrob Chemother; 1995 Oct; 36(4):737-8. PubMed ID: 8591951
    [No Abstract]   [Full Text] [Related]  

  • 16. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.
    Vila J; Ruiz J; Marco F; Barcelo A; Goñi P; Giralt E; Jimenez de Anta T
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2477-9. PubMed ID: 7840592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV.
    Breines DM; Ouabdesselam S; Ng EY; Tankovic J; Shah S; Soussy CJ; Hooper DC
    Antimicrob Agents Chemother; 1997 Jan; 41(1):175-9. PubMed ID: 8980775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections.
    Komp Lindgren P; Marcusson LL; Sandvang D; Frimodt-Møller N; Hughes D
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2343-51. PubMed ID: 15917531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of quinolone resistance mechanisms in Neisseria gonorrhoeae isolates in vitro.
    Tanaka M; Sakuma S; Takahashi K; Nagahuzi T; Saika T; Kobayashi I; Kumazawa J
    Sex Transm Infect; 1998 Feb; 74(1):59-62. PubMed ID: 9634306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of action of quinolones against Escherichia coli DNA gyrase.
    Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.